Modality Solutions Achieves ISO 9001:2015 Recertification, Expands Certification Scope to Greenwood Laboratory
Modality Solutions has successfully achieved recertification to the ISO 9001:2015 standard, reaffirming its commitment...
read Details
Vertex announces UK approval for CASGEVY™
Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).
We are proud to have contributed to Vertex’s cold chain with full transport validation support, including transport simulation testing using Modality Solutions’ Advantage Transport Simulation Laboratory™.
Stay on top of the industry trends
You may also like
Modality Solutions, Suttons Creek, CLINTREX, and ToxStrategies—announce their unification under a new brand: BlueRidge Life Sciences
Today, four leading life science companies—Suttons Creek, Modality Solutions, CLINTREX, and ToxStrategies—announce their unification...
read Details
Modality Solutions’ New Greenwood Lab Slashes Lead Times and Expands Testing
Modality Solutions is proud to announce the launch of our new Greenwood Lab—a state-of-the-art...
read Details